Cipla has announced further investment of up to Rs 26 crore in Achira Labs, a company specializing in point-of-care medical test kits. This investment will be made in four tranches, contingent upon the achievement of specific milestones. After the first tranche, Cipla will hold 27.27% of the total voting rights in Achira. This decision follows Cipla’s initial acquisition of a 21.05% stake in Achira Labs in June 2022. Achira Labs, based in Bengaluru, focuses on developing and commercializing regulatory-approved medical diagnostic products using microfluidic technology.
